Magazine: Cleanroom chronicles
With tighter regulations around biopharma manufacturing and the emergence of advanced therapies, cleanroom design is being fundamentally reshaped. This month's…
23 Oct 2025
Demystifying the immune system with the help of AI-ML
Immunotherapy drugs continue to gain momentum across a growing range of disease areas with blockbusters such as MSD's Keytruda (pembrolizumab) and BMS’s Opdivo (nivolumab) generating billions in annual revenue since…
16 Oct 2025
From Nobel to next-gen: Sweden’s quiet life sciences ascent
Sweden’s place on the frontier of science has a long history, with the capital Stockholm coming to a standstill every year since 1901 in eager anticipation of the Nobel Prize…
13 Oct 2025
New US biotech hubs show potential amid onshoring requests
The US has always been a key player in the pharmaceutical industry, with prominent names like Pfizer, Eli Lilly and Bristol Myers Squibb (BMS) all becoming market pioneers in the…
10 Oct 2025
Pharma R&D set to endure despite rising MFN costs
Pharmaceutical research and development (R&D) is unlikely to be significantly impacted by most favored nation (MFN) pricing, according to industry experts. The US bears the highest drug costs globally, a…
30 Sep 2025
NewCo licensing models are tipping deals in favour of China’s biotechs
As pharma companies continue to license candidates developed in China, experts say a particular licensing model is allowing the country's burgeoning biotechs to leverage vast global capital and R&D while…
26 Sep 2025
The Baltics: a region punching above its weight on the global life sciences stage
Once best-known on the world stage as a country with a rich basketball history, a sport so deeply ingrained in Lithuanian national identity and culture it is considered by many…